Storyline

New insights into metabolic adaptation and developmental identity in neuroendocrine prostate cancer

Recent studies have advanced understanding of neuroendocrine prostate cancer (NEPC), a treatment-resistant form of prostate cancer.

Published 2026-07-08 16:08 UTCUpdated 2026-07-08 23:58 UTC
Current brief openSource links open
This current storyline is open here with summary, metadata, source links, continuity context, and full evidence. Paid is for compare-over-time, alerts, exports, and workflow.
No card needed for the free brief.
Evidence trail (top sources)
top sources (1 domains)domains are deduped. counts indicate coverage, not truth.
1 top source shown
limited source diversity in top sources
Overview

Recent studies have advanced understanding of neuroendocrine prostate cancer (NEPC), a treatment-resistant form of prostate cancer.

Score total
0.75
Momentum 24h
2
Posts
2
Origins
1
Source types
1
Duplicate ratio
0%
Why now
  • Recent preclinical studies provide new mechanistic insights into NEPC adaptation to hypoxia.
  • Integrated multi-omics analyses reveal the fetal neuroendocrine-like identity of NEPC cells.
  • These findings open avenues for developing targeted therapies against a lethal prostate cancer subtype.
Why it matters
  • Identifies metabolic vulnerabilities in NEPC that could be targeted therapeutically.
  • Clarifies the developmental lineage of NEPC, aiding biomarker and drug target discovery.
  • Supports novel combination strategies to overcome treatment resistance in advanced prostate cancer.
Continuity snapshot
  • Trend status: insufficient_history.
  • Continuity stage: seed.
  • Current status: open.
  • 2 current source-linked posts are attached to this storyline.
All evidence
All evidence
Show filters & breakdown
Posts loaded: 0Publishers: 1Origin domains: 1Duplicates: -
Showing 1 / 0
Top publishers (this list)
  • bioRxiv (all subjects) (1)
Top origin domains (this list)
  • biorxiv.org (1)